ONLINE DATABASE SEARCH - HIV-LS-291-MEMO
1. 42958 HIV-LS-291; PUBMED-HIV-3/9/2004
HIV fitness and resistance as covariates associated with the appearance of mutations under antiretroviral treatment
Perno, CF, Cenci, A, Piro, C, D'Arrigo, R, Marcon, L, Ceccherini-Silberstein, F, Ascoli, Marchetti F, Calio, R, and Antinori, A
Scand J Infect Dis Suppl 2003. 35 Suppl 106: 37-40
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15000581&dopt=abstract
2. 42959 HIV-LS-291; PUBMED-HIV-3/9/2004
Detection of Drug-Resistant Minority Variants of HIV-1 During Virologic Failure of Indinavir, Lamivudine, and Zidovudine
Dykes, C, Najjar, J, Bosch, RJ, Wantman, M, Furtado, M, Hart, S, Hammer, SM, and Demeter, LM
J Infect Dis 2004. 189(6): 1091-6
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14999613&dopt=abstract
3. 42960 HIV-LS-291; PUBMED-HIV-3/9/2004
Enfuvirtide, a new fusion inhibitor for therapy of human immunodeficiency virus infection
Hardy, H and Skolnik, PR
Pharmacotherapy 2004. 24(2): 198-211
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14998221&dopt=abstract
4. 42961 HIV-LS-291; PUBMED-HIV-3/9/2004
Crystal Structures of a Multidrug-Resistant Human Immunodeficiency Virus Type 1 Protease Reveal an Expanded Active-Site Cavity
Logsdon, BC, Vickrey, JF, Martin, P, Proteasa, G, Koepke, JI, Terlecky, SR, Wawrzak, Z, Winters, MA, Merigan, TC, and Kovari, LC
J Virol 2004. 78(6): 3123-3132
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14990731&dopt=abstract
5. 42962 HIV-LS-291; SCIFINDER-HIV-3/2/2004
Rational Design of Inhibitors of HIV-1 TAR RNA through the Stabilisation of Electrostatic \"Hot Spots\"
Davis, Ben, Afshar, Mohammad, Varani, Gabriele, Murchie, Alastair IH, Karn, Jonathan, Lentzen, Georg, Drysdale, Martin, Bower, Justin, Potter, Andrew J, Starkey, Ian D, Swarbrick, Terry, and Aboul-ela, Fareed
Journal of Molecular Biology 2004. 336(2): 343-356
6. 42963 HIV-LS-291; PUBMED-HIV-3/9/2004
Anti-HIV-1 activity of pyrryl aryl sulfone (PAS) derivatives: synthesis and SAR studies of novel esters and amides at the position 2 of the pyrrole nucleus
Silvestri, R, Artico, M, La Regina, G, De Martino, G, La ColLa M, Loddo, R, and La ColLa P
Farmaco 2004. 59(3): 201-10
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14987983&dopt=abstract
7. 42964 HIV-LS-291; PUBMED-HIV-3/9/2004
Plant Substances as Anti-HIV Agents Selected According to Their Putative Mechanism of Action
Cos, P, Maes, L, Vanden, Berghe D, Hermans, N, Pieters, L, and Vlietinck, A
J Nat Prod 2004. 67(2): 284-93
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14987070&dopt=abstract
8. 42965 HIV-LS-291; PUBMED-HIV-3/9/2004
Anti-AIDS Agents. Part 57; Actein, an anti-HIV principle from the rhizome of Cimicifuga racemosa (black cohosh), and the anti-HIV activity of related saponins
Sakurai, N, Wu, JH, Sashida, Y, Mimaki, Y, Nikaido, T, Koike, K, Itokawa, H, and Lee, KH
Bioorg Med Chem Lett 2004. 14(5): 1329-32
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14980692&dopt=abstract
9. 42966 HIV-LS-291; PUBMED-HIV-3/9/2004
Synthesis of 5'-C-methyl-1',3'-dioxolan-4'-yl nucleosides
Du, J, Patterson, S, Shi, J, Chun, BK, Stuyver, LJ, and Watanabe, KA
Bioorg Med Chem Lett 2004. 14(5): 1243-5
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14980674&dopt=abstract
10. 42967 HIV-LS-291; PUBMED-HIV-3/9/2004
Design and synthesis of photoactivatable aryl diketo acid-containing HIV-1 integrase inhibitors as potential affinity probes
Zhang, X, Marchand, C, Pommier, Y, and Burke, TR Jr
Bioorg Med Chem Lett 2004. 14(5): 1205-7
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14980666&dopt=abstract
11. 42968 HIV-LS-291; SCIFINDER-HIV-3/2/2004
Anti-HIV agent ((Fuso Pharmaceutical Industries, Ltd. Japan)
Wakamiya, Nobutaka, Ohtani, Katsuki, Sakamoto, Takashi, Keshi, Hiroyuki, and Kishi, Yuichiro
PATENT: WO 2004002511 A1; ISSUE DATE: 20040108
APPLICATION: 2003; PP: 44 pp.
12. 42969 HIV-LS-291; SCIFINDER-HIV-3/2/2004
Antiviral regimens with once daily oral zidovudine for HIV infections( (Glaxo Group Limited, UK)
Keller, Amy Lee and Paes, Dominic Joseph Vincent
PATENT: WO 2004002498 A1; ISSUE DATE: 20040108
APPLICATION: 2003; PP: 20 pp.
13. 42970 HIV-LS-291; SCIFINDER-HIV-3/2/2004
Inhibition of HIV-1 Replication by Cell-penetrating Peptides Binding Rev
Roisin, Armelle, Robin, Jean-Philippe, Dereuddre-Bosquet, Nathalie, Vitte, Anne-Laure, Dormont, Dominique, Clayette, Pascal, and Jalinot, Pierre
Journal of Biological Chemistry 2004. 279(10): 9208-9214
14. 42971 HIV-LS-291; PUBMED-HIV-3/9/2004
Enhanced gene silencing of HIV-1 specific siRNA using microRNA designed hairpins
Boden, D, Pusch, O, Silbermann, R, Lee, F, Tucker, L, and Ramratnam, B
Nucleic Acids Res 2004. 32(3): 1154-8
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14966264&dopt=abstract
15. 42972 HIV-LS-291; PUBMED-HIV-3/9/2004
A single amino acid determinant governs the species-specific sensitivity of APOBEC3G to Vif action
Mangeat, B, Turelli, P, Liao, S, and Trono, D
J Biol Chem 2004
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14966139&dopt=abstract
16. 42973 HIV-LS-291; PUBMED-HIV-3/9/2004
Antiviral sulfonamide derivatives
Supuran, CT, Innocenti, A, Mastrolorenzo, A, and Scozzafava, A
Mini Rev Med Chem 2004. 4(2): 189-200
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14965291&dopt=abstract
17. 42974 HIV-LS-291; PUBMED-HIV-3/9/2004
Artificial neural networks: non-linear QSAR studies of HEPT derivatives as HIV-1 reverse transcriptase inhibitors
Douali, L, Villemin, D, Zyad, A, and Cherqaoui, D
Mol Divers 2004. 8(1): 1-8
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14964783&dopt=abstract
18. 42975 HIV-LS-291; SCIFINDER-HIV-3/2/2004
Prepn of 5'-choline phosphate 3'-azido 3'-deoxythymidine as anti-AIDS agents((Zakrytoe Aktsionernoe Obshcestvo 'Proizvodstvenno -Kommercheskaya Assotsiatsiya Azt', Russia)
Shipitsyn, Alexander Valer'evich, Yasko, Maxim Vladimirovich, Shirokova, Elena Anatol'evna, Koukhanova, Marina Konstantinovna, Pronayeva, Tatiana Rudolfovna, Feduk, Nina Vladimirovna, Pokrovsky, Andrey Georgievich, Gosselin, Gilles, and Perigaud, Christian
PATENT: WO 2004011480 A1; ISSUE DATE: 20040205
APPLICATION: 2003; PP: 13 pp.
19. 42976 HIV-LS-291; SCIFINDER-HIV-3/2/2004
Preparation of indolyl-, azaindolyl-, and related heterocyclic ureido and thioureido piperazines for treatment of HIV and AIDS((Bristol-Myers Squibb Company, USA)
Regueiro-Ren, Alicia, Xue, Qiufen May, Kadow, John F, and Taylor, Malcolm
PATENT: WO 2004011425 A2; ISSUE DATE: 20040205
APPLICATION: 2003; PP: 107 pp.
20. 42977 HIV-LS-291; SCIFINDER-HIV-3/2/2004
Substituted heterocyclic compounds as modulators of the CCR5 receptor, and therapeutic use((Smithkline Beecham Corporation, USA)
Bondinell, William E and Neeb, Michael J
PATENT: WO 2004010942 A2; ISSUE DATE: 20040205
APPLICATION: 2003; PP: 50 pp.
21. 42978 HIV-LS-291; WOS-HIV-2/29/2004
The first generation of candidate HIV-1 vaccines can induce antibodies able to neutralize primary isolates in assays with extended incubation phases
Donners, H, Vermoesen, T, Willems, B, Davis, D, and Van der, Groen G
VACCINE 2003. 22(1): 104-111
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000188791100015
22. 42979 HIV-LS-291; WOS-HIV-2/29/2004
Cytotoxic and anti-HIV-1 constituents from leaves and twigs of Gardenia tubifera
Reutrakul, V, Krachangchaeng, C, Tuchinda, P, Pohmakotr, M, Jaipetch, T, Yoosook, C, Kasisit, J, Sophasan, S, Sujarit, K, and Santisuk, T
TETRAHEDRON 2004. 60(7): 1517-1523
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000188785600009
23. 42980 HIV-LS-291; SCIFINDER-HIV-3/2/2004
Preparation of aromatic amines bearing tetraazacyclotetradecanyl group as nontoxic CCR5 antagonists and HIV antiviral agents((Kureha Chemical Industry Co., Ltd. Japan)
Suzuki, Shigeru, Takemura, Yoshiyuki, Sakauchi, Kenji, Hirose, Kunitaka, and Taninaka, Mikio
PATENT: JP 2004043324 A2; ISSUE DATE: 20040212
APPLICATION: 2002-3331; PP: 12 pp.
24. 42981 HIV-LS-291; WOS-HIV-2/29/2004
The effect of human immunodeficiency virus-1 protease inhibitors on the toxicity of a variety of cells
Germinario, RJ and Colby-Germinario, SP
IN VITRO CELL DEV-AN 2003. 39(7): 275-279
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000188859600005
25. 42982 HIV-LS-291; WOS-HIV-2/29/2004
Capravirine - Anti-HIV agent - Reverse transcriptase inhibitor
Sorbera, LA, Castaner, J, and Bayes, M
DRUG FUTURE 2003. 28(12): 1149-1158
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000188806500001
26. 42983 HIV-LS-291; WOS-HIV-2/29/2004
Specific inhibition of HIV-1 coreceptor activity by synthetic peptides corresponding to the predicted extracellular loops of CCR5
Agrawal, L, VanHorn-Ali, Z, Berger, EA, and Alkhatib, G
BLOOD 2004. 103(4): 1211-1217
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000188828200014
27. 42984 HIV-LS-291; WOS-HIV-2/29/2004
CXCR4 engagement is required for HIV-1-induced L-selectin shedding
Wang, JF, Marschner, S, and Finkel, TH
BLOOD 2004. 103(4): 1218-1221
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000188828200015
28. 42985 HIV-LS-291; WOS-HIV-2/29/2004
In vitro activity of stampidine against primary clinical human immunodeficiency virus isolates
Uckun, FM, Pendergrass, S, Qazi, S, and Venkatachalam, TK
ARZNEIMITTEL-FORSCH 2004. 54(1): 69-77
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000188832700011
29. 42986 HIV-LS-291; WOS-HIV-2/29/2004
Protease mutations in HIV-1 non-B strains infecting drug-naive villagers of Cameroon
Konings, FAJ, Zhong, P, Agwara, M, Agyingi, L, Zekeng, L, Achkar, JM, Ewane, L, Saa, D, Ze, EA, Kinge, T, and Nyambi, PN
AIDS RES HUM RETROV 2004. 20(1): 105-109
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000188861700012
30. 42987 HIV-LS-291; WOS-HIV-2/29/2004
The CCR5 and CXCR4 coreceptors - Central to understanding the transmission and pathogenesis of human immunodeficiency virus type 1 infection
Moore, JP, Kitchen, SG, Pugach, P, and Zack, JA
AIDS RES HUM RETROV 2004. 20(1): 111-126
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000188861700013
31. 42988 HIV-LS-291; WOS-HIV-3/7/2004
Role for CCR5 Delta 32 protein in resistance to R5, R5X4, and X4 human immunodeficiency virus type 1 in primary CD4(+) cells
Agrawal, L, Lu, XH, Qingwen, J, VanHorn-Ali, Z, Nicolescu, IV, McDermott, DH, Murphy, PM, and Alkhatib, G
J VIROL 2004. 78(5): 2277-2287
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000189019300012
32. 42989 HIV-LS-291; WOS-HIV-3/7/2004
Structure-based drug design targeting an inactive RNA conformation: Exploiting the flexibility of HIV-1 TAR RNA
Murchie, AIH, Davis, B, Isel, C, Afshar, M, Drysdale, MJ, Bower, J, Potter, AJ, Starkey, ID, Swarbrick, TM, Mirza, S, Prescott, CD, Vaglio, P, Aboul-eLa F, and Karn, J
J MOL BIOL 2004. 336(3): 625-638
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000188948500006
33. 42990 HIV-LS-291; WOS-HIV-3/7/2004
Vif overcomes the innate antiviral activity of APOBEC3G by promoting its degradation in the ubiquitin-proteasome pathway
Mehle, A, Strack, B, Ancuta, P, Zhang, CS, McPike, M, and Gabuzda, D
J BIOL CHEM 2004. 279(9): 7792-7798
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000189103300053
34. 42991 HIV-LS-291; WOS-HIV-3/7/2004
Inhibition of intra- and extra-cellular Tat function and HIV expression by pertussis toxin B-oligomer
Rizzi, C, Alfano, M, Bugatti, A, Camozzi, M, Poli, G, and Rusnati, M
EUR J IMMUNOL 2004. 34(2): 530-536
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000188980400026
35. 42992 HIV-LS-291; WOS-HIV-3/7/2004
Synthesis of novel 5 '-hydrogenphosphonothioate derivatives of AZT, d4T and ddI
Jin, Y, Sun, M, Fu, H, and Zhao, YF
CHEM LETT 2004. 33(2): 116-117
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000189038400017
36. 42993 HIV-LS-291; WOS-HIV-3/7/2004
Adverse effects of antiretroviral therapy for HIV infection
Montessori, V, Press, N, Harris, M, Akagi, L, and Montaner, JSG
CAN MED ASSOC J 2004. 170(2): 229-238
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000189082300030
37. 42994 HIV-LS-291; WOS-HIV-3/7/2004
Risk of failure in patients with 215 HIV-1 revertants starting their first thymidine analog-containing highly active antiretroviral therapy
Violin, M, Cozzi-Lepri, A, Velleca, R, Vincenti, A, D'Elia, S, Chiodo, F, Ghinelli, F, Bertoli, A, Monforte, AD, Perno, CF, Moroni, M, and Balotta, C
AIDS 2004. 18(2): 227-235
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000188968100012
38. 42995 HIV-LS-291; WOS-HIV-3/7/2004
Novel 5,10-dihydrobenzo[b][1,8]napthyridine N-oxides as non-nucleoside reverse transcriptase inhibitors of HIV-1 with high potency against clinically relevant mutants variants.
Johnson, BL, Tarby, CM, Srivastava, A, Bakthavatchalam, R, Lin, QY, Cocuzza, AJ, Bilder, DM, Bacheler, LT, Diamond, S, Jeffrey, S, Klabe, RM, Cordova, BC, Garber, S, Logue, K, Erickson-Viitanen, SK, Trainor, GL, Anderson, PS, and Rodgers, JD
ABSTR PAP AM CHEM S 2003. 226: U24
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000187062500129
39. 42996 HIV-LS-291; WOS-HIV-3/7/2004
Design, antiviral and pharmacokinetic profiles of potent 1,3,4-trisubstituted pyrrolidine CCR5 receptor antagonists for the treatment of HIV-1 infection.
Kim, D, Wang, LP, Hale, JJ, Lynch, C, Budhu, RJ, MacCoss, M, Mills, SG, Malkowitz, L, Gould, SL, DeMartino, JA, Springer, MS, Hazuda, D, Kessler, J, Danzeisen, R, CarelLa A, Holmes, K, Lineberger, J, Schleif, WA, and Emini, EA
ABSTR PAP AM CHEM S 2003. 226: U30
HYPERLINK:
http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000187062500162